Market Tracker

07/31 5:16pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

During the Trading Day
47.87 +0.53 / +1.12%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
47.87 0.00 / 0.00%
 
Volume: 16.8K

Today’s Trading

Previous close47.34
Today’s open47.08
Day’s range46.88 - 48.47
Volume877,727
Average volume (3 months)990,838
Market cap$5.9B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-35.43%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book27.84

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+0.75+0.54%
HZNPHorizon Pharma PLC+0.54+1.49%
ICPTIntercept Pharmaceut...+2.01+0.77%
ANACAnacor Pharmaceutica...+0.49+0.33%
Data as of 4:14pm ET, 07/31/2015

Financials

Last reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts